Trial Profile
Ziprasidone intramuscular/oral in the treatment of acute exacerbation of schizophrenia or schizoaffective disorder: A six-week open administration study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Ziprasidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Pfizer
- 16 Apr 2008 New trial record.